Publications by authors named "Andrew B Sharabi"

22Publications

Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer.

Semin Radiat Oncol 2020 Oct;30(4):273-280

Department of Radiation Medicine and Applied Sciences, UC San Diego, La Jolla, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2020.05.003DOI Listing
October 2020

High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers.

Mol Cancer Ther 2020 10 3;19(10):2139-2145. Epub 2020 Aug 3.

Division of Hematology/Oncology, and Center for Personalized Cancer Therapy, Department of Medicine, University of California, Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-20-0161DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541603PMC
October 2020

B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade.

Clin Cancer Res 2020 Jul 19;26(13):3345-3359. Epub 2020 Mar 19.

Department of Radiation Medicine and Applied Sciences, Moores Cancer Center, University of California, San Diego, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-3211DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334097PMC
July 2020

HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.

Cancer Res 2020 02 17;80(4):732-746. Epub 2019 Dec 17.

Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-19-1771DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024675PMC
February 2020

A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy.

Front Immunol 2019 18;10:491. Epub 2019 Mar 18.

Department of Radiation Medicine and Applied Sciences, San Diego Moores Cancer Center, University of California, San Diego, San Diego, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.00491DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431643PMC
September 2020

Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics.

Clin Cancer Res 2019 07 27;25(14):4211-4223. Epub 2019 Feb 27.

Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-0871DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635035PMC
July 2019

Stereotactic Body Radiation Therapy Versus Surgery for Early Lung Cancer Among US Veterans.

Ann Thorac Surg 2018 Feb 30;105(2):425-431. Epub 2017 Nov 30.

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; Clinical and Translational Research Institute, University of California San Diego, La Jolla, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2017.07.048DOI Listing
February 2018

Effect of CD4 Count on Treatment Toxicity and Tumor Recurrence in Human Immunodeficiency Virus-Positive Patients With Anal Cancer.

Int J Radiat Oncol Biol Phys 2018 02 22;100(2):478-485. Epub 2017 Sep 22.

Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California; Clinical and Translational Research Institute, University of California, San Diego, La Jolla, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.09.034DOI Listing
February 2018

Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy.

Lancet Oncol 2015 Oct;16(13):e498-509

Department of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S147020451500007
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(15)00007-8DOI Listing
October 2015

Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen.

Cancer Immunol Res 2015 Apr 19;3(4):345-55. Epub 2014 Dec 19.

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland. Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0196DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390444PMC
April 2015

Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer.

J Immunother Cancer 2014 14;2:14. Epub 2014 May 14.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA ; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2051-1426-2-14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039332PMC
June 2014

Enhanced generation of myeloid lineages in hematopoietic differentiation from embryonic stem cells by silencing transcriptional repressor Twist-2.

Cloning Stem Cells 2009 Dec;11(4):523-33

Department of Immunology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/clo.2009.0020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883497PMC
December 2009

Twist-2 controls myeloid lineage development and function.

PLoS Biol 2008 Dec;6(12):e316

Department of Immunology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pbio.0060316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602725PMC
December 2008